The cheapest legitimate route to weekly tirzepatide in the United States in 2026 is a compounded telehealth program priced at $179 a month. The cheapest brand-name route is LillyDirect Zepbound vials at $349. The most expensive route — pharmacy cash-pay for brand pens — is over $1,000. Same molecule across all three. The only difference is who you went through to get it.
This article ranks every meaningful direct-to-consumer telehealth GLP-1 provider by total monthly cost, with verified April 2026 pricing. We have grouped them into four tiers: aggressive value, mid-market, premium, and brand-name-only. We tell you who wins each tier and what trade-offs each makes.
How we compared
Pricing in the GLP-1 telehealth market is intentionally hard to compare because providers slice their pricing in different ways: some charge a flat monthly fee that includes everything, others bundle a "membership" with a separate medication cost, others price by dose tier. To normalize, we asked the same question of every provider: what is the all-in monthly cost of a 5 mg/week tirzepatide program for a new patient in month one, including the initial consultation, lab fees if required, the medication itself, and shipping?
5 mg is the most common starting maintenance dose and is representative of where most patients spend most of their treatment time. We excluded providers that do not publish pricing, providers that require an in-person visit, and providers that are reseller-of-resellers without a clear pharmacy partner.
Tier 1: aggressive value ($149–$199/month)
The bottom of the price market in 2026 is occupied by providers using high-volume 503A pharmacy partnerships, minimal frills, and competitive customer-acquisition pricing. These programs deliver real compounded tirzepatide, but the wraparound — coaching, lab monitoring, dose adjustments — is more limited than premium tiers. They are the right pick for patients who know what they want, are price-sensitive, and do not need extensive hand-holding.
| Provider | Monthly cost (5 mg) | Includes | Verdict |
|---|---|---|---|
| Gala GLP-1 | $179 | Compounded tirzepatide, telehealth visits, shipping | Best price-to-value |
| MadeMed | $169 – $189 | Compounded options, basic support | Lean but legit |
| Get Thin GLP-1 | $189 | Compounded weight loss program, dose-tier pricing | Solid value |
| Novi Weight Loss | $179 – $199 | Compounded GLP-1, newer entrant | Watch this one |
Tier 1 trade-offs
What you give up in tier 1: dose flexibility (some programs are stricter about titration speed), customer service responsiveness (smaller teams, longer email turnaround), and program "warmth" (you are unlikely to have a dedicated coach). What you get: real medication at a real price that beats every other tier by a wide margin. If you are a self-directed patient who has read up on tirzepatide and wants the lowest legitimate cost, tier 1 is your tier.
Tier 2: mid-market ($199–$299/month)
The mid-market is where most US compounded GLP-1 patients land. These programs offer better customer support, more dose-adjustment flexibility, and typically include an initial lab panel and ongoing check-ins. The price premium over tier 1 is real but modest, and most patients find the additional support worth $30 to $80 a month.
| Provider | Monthly cost (5 mg) | Includes | Verdict |
|---|---|---|---|
| Yucca Health | $229 | Compounded tirzepatide, lab panel, telehealth, dietitian access | Strong all-rounder |
| Care Bare Rx | $249 | Compounded tirzepatide, intake quiz onboarding, support | Fast onboarding |
| Sprout Health | $249 | Clinical-grade compound, transparent pricing | Solid mid-market pick |
| Strut Health | $259 | Telehealth GLP-1, transparent pricing | Good for men's-health bundles |
| MEDVi | $229 | Oral GLP-1 option, lab-monitored | No-needle alternative |
MEDVi's signature offering is an oral compounded semaglutide rather than weekly injection. The clinical evidence base for oral semaglutide outside of brand-name Rybelsus is limited, and patient response is more variable than with subcutaneous formulations. For needle-averse patients it is a legitimate option to discuss with a prescriber, but the efficacy expectation should be set conservatively compared to injectable tirzepatide.
Tier 3: premium compounded ($299–$499/month)
Premium tier programs invest heavily in clinical wraparound: dedicated care teams, frequent lab monitoring, dose optimization algorithms, behavioral coaching, and patient portals. The medication itself is the same molecule from similar pharmacy partners — you are paying for the program, not the drug. For patients who want medical supervision built in, premium tier is the right call.
| Provider | Monthly cost (5 mg) | Includes | Verdict |
|---|---|---|---|
| Embody | $299 – $399 | Custom-formulated tirzepatide, premium support, dose optimization | Premium-tier leader |
| Wellorithm | $329 | Algorithm-driven dose optimization, clinical monitoring | Best for data-driven patients |
| Tonik | ~$299 – $449 | GLP-1 + longevity stack, % pricing model | For stack-builders |
Tier 4: brand-name only routes ($349–$649/month)
For patients who specifically want brand-name FDA-approved Zepbound or Wegovy and are willing to pay the premium, the cheapest legitimate routes in 2026 are the manufacturer self-pay programs and Sesame Care's brand-prescribing model.
| Route | Monthly cost | What you get | Verdict |
|---|---|---|---|
| LillyDirect Zepbound vials | $349 (2.5 mg) – $649 (10 mg) | Brand-name FDA-approved Zepbound, vial format | Cheapest brand route |
| NovoCare Direct Wegovy | ~$499 | Brand-name FDA-approved Wegovy, vial format | Brand semaglutide cash-pay |
| Sesame Care | $199 visit + medication separately | Brand-name prescription, fill at retail or LillyDirect | Best for brand-name only |
Sesame Care is structured differently from the other providers in this article. Sesame is a direct-pay marketplace that connects patients with prescribers who write for brand-name Wegovy, Zepbound, Mounjaro, and Ozempic. The patient then fills the prescription at retail pharmacy or via the manufacturer's direct-pay program (LillyDirect or NovoCare Direct). Sesame does not dispense compounded medication. For patients who want brand-name FDA-approved tirzepatide and have a flexible enough budget to absorb the manufacturer self-pay price, Sesame is the cleanest brand-name pathway.
Hidden costs that change the ranking
Headline monthly pricing rarely tells the full story. The four hidden cost categories that can move a provider up or down the ranking by $20-$80 a month:
1. Initial consultation and lab fees. Some providers bundle the intake visit and required labs into the monthly price; others charge a one-time $50-$199 onboarding fee. For a 12-month patient relationship this gets amortized to $4-$17 a month.
2. Dose-tier pricing. Some providers charge a flat monthly fee regardless of dose; others charge more for higher doses (which use more medication). If you titrate up to 10 mg or 12.5 mg/week, your true monthly cost may be 20-50% higher than the entry-level quote.
3. Shipping and cold-chain fees. Tirzepatide requires refrigerated shipping. Most providers include this in the monthly price; a few charge $15-$45 per shipment as an extra.
4. Subscription lock-in vs. month-to-month. Some providers offer an attractive monthly price only with a 3- or 6-month prepay commitment. Month-to-month pricing at the same provider may be 15-30% higher.
If a provider quotes you "$179/month" but the small print says that price is for 2.5 mg only and the maintenance dose costs $279, your real long-run monthly cost is $279, not $179. Always ask: "What is the price at my likely maintenance dose of 5 mg or higher?" before signing up. The honest providers in this market quote consistent prices across doses; the aggressive marketers do not.
Our picks by use case
Lowest legitimate cost, period: Gala GLP-1 at $179/month for compounded tirzepatide. The aggressive-value pick that genuinely beats the market on price without obvious quality compromises.
Best balance of price and clinical support: Yucca Health at $229/month — full lab panel, dietitian access, telehealth visits, and a fair price for the package.
Best premium compounded experience: Embody at $299-$399/month — custom-formulated tirzepatide with premium clinical wraparound and dose optimization for patients who want concierge-level care.
Best brand-name only route: Sesame Care for the prescription, then fill via LillyDirect Zepbound vials at $349-$649/month. This is the cheapest legitimate path to FDA-approved brand-name tirzepatide.
Best for needle-averse patients: MEDVi for oral compounded semaglutide. Set efficacy expectations conservatively versus injectable tirzepatide but if you cannot do needles, this is the best telehealth option.
The bottom line
The GLP-1 telehealth market in 2026 has consolidated into clear price tiers with reasonably consistent quality at each tier. The $179 aggressive-value tier is real and works for self-directed patients. The $229-$299 mid-market tier offers meaningfully better support for a modest premium. The $299-$499 premium tier is for patients who value concierge clinical care. The $349-$649 brand-name tier is for patients who specifically want FDA-approved brand product.
The patient who pays $1,000+ a month at retail pharmacy in 2026 is doing so because they did not know any of these alternatives existed. For everyone else, the question is not "can I afford a GLP-1?" but "which tier matches my situation?"
For the brand-vs-compounded breakdown in detail, see Mounjaro vs Zepbound 2026: Same Drug, Different Price. For the year-long cost projection across all routes, see Zepbound vs Mounjaro Cost Comparison 2026.